☰

Jonathan Chou, Ph.D. - Publications

Affiliations: 
2012 Biomedical Sciences University of California, San Francisco, San Francisco, CA 
Area:
role of the cellular microenvironment and intercellular communication in breast development and cancer
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhao SG, Chen WS, Li H, Foye A, Zhang M, Sjöström M, Aggarwal R, Playdle D, Liao A, Alumkal JJ, Das R, Chou J, Hua JT, Barnard TJ, Bailey AM, et al. The DNA methylation landscape of advanced prostate cancer. Nature Genetics. PMID 32661416 DOI: 10.1038/S41588-020-0648-8  0.323
2020 Chou J, Quigley DA, Robinson TM, Feng FY, Ashworth A. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. Cancer Discovery. PMID 32071145 DOI: 10.1158/2159-8290.Cd-19-0528  0.367
2020 Chu C, Alshalalfa M, Sjöström M, Zhao S, Herlemann A, Chou J, Mahal BAV, Kishan AU, Spratt DE, Karnes J, Small EJ, Wong AC, Porten SP, Hope T, Davicioni E, et al. Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer. Journal of Clinical Oncology. 38: 295-295. DOI: 10.1200/Jco.2020.38.6_Suppl.295  0.312
2020 Chu C, Alshalalfa M, Sjöström M, Zhao S, Herlemann A, Chou J, Baskin AL, Mahal BAV, Spratt DE, Cooperberg MR, Small EJ, Aggarwal RR, Wong AC, Porten SP, Hope T, et al. Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer. Journal of Clinical Oncology. 38: 24-24. DOI: 10.1200/Jco.2020.38.6_Suppl.24  0.321
2020 Atreya CE, Park M, Grenert JP, Behr S, Gonzalez A, Chou J, Maisel S, Friedlander TW, Freise CE, Shoji J, Semrad TJ, Chin-Hong P, Collisson EA, Van Ziffle J. Molecular characterization of a gastric cancer transmitted from an organ donor to four transplant recipients. Journal of Clinical Oncology. 38: 414-414. DOI: 10.1200/Jco.2020.38.4_Suppl.414  0.335
2020 Natesan D, Martell H, Devine P, Stohr BA, Grenert JP, Van Ziffle J, Joseph NM, Bastian BC, Umetsu SE, Onodera C, Chan E, Desai A, Wong AC, Porten SP, Chou J, et al. Correlation of tumor mutational burden (TMB) with molecular profiling and clinical characteristics in patients with bladder cancer. Journal of Clinical Oncology. 38: e17025-e17025. DOI: 10.1200/Jco.2020.38.15_Suppl.E17025  0.314
2020 Littlepage LE, Ewald AJ, Alexander C, Casbon A, Lu P, Kessenbrock K, Provot S, Phillips JJ, Kouros-Mehr H, Chan M, Welm B, Lilla JN, Chou J, Lawson D, Lemieux G, et al. Zena Werb (1945–2020) Cell Stem Cell. 27: 356-358. DOI: 10.1016/J.Stem.2020.08.006  0.687
2020 Littlepage LE, Ewald AJ, Alexander C, Casbon A, Lu P, Kessenbrock K, Provot S, Phillips JJ, Kouros-Mehr H, Chan M, Welm B, Lilla JN, Chou J, Lawson D, Lemieux G, et al. Zena Werb (1945–2020) Developmental Cell. 54: 299-301. DOI: 10.1016/J.Devcel.2020.07.012  0.687
2019 Owyong M, Chou J, van den Bijgaart RJ, Kong N, Efe G, Maynard C, Talmi-Frank D, Solomonov I, Koopman C, Hadler-Olsen E, Headley M, Lin C, Wang CY, Sagi I, Werb Z, et al. MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy. Life Science Alliance. 2. PMID 31727800 DOI: 10.26508/lsa.201800226  0.501
2019 Reimers MA, Yip SM, Zhang L, Cieslik M, Dhawan M, Montgomery B, Wyatt AW, Chi KN, Small EJ, Chinnaiyan AM, Alva AS, Feng FY, Chou J. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer. European Urology. PMID 31640893 DOI: 10.1016/J.Eururo.2019.09.036  0.317
2019 Kothari V, Goodwin JF, Zhao SG, Drake JM, Yin Y, Chang SL, Evans JR, Wilder-Romans K, Gabbara K, Dylgjeri E, Chou J, Sun G, Tomlins SA, Mehra R, Hege K, et al. DNA-dependent protein kinase drives prostate cancer progression through transcriptional regulation of the Wnt signaling pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31266829 DOI: 10.1158/1078-0432.Ccr-18-2387  0.362
2019 Reimers MA, Abida W, Chou J, George DJ, Heath EI, McKay RR, Pachynski RK, Zhang J, Choi JE, Feng FY, Neshewat G, Cieslik M, Daignault-Newton S, Small EJ, Chinnaiyan A, et al. IMPACT: Immunotherapy in patients with metastatic cancers and CDK12 mutations. Journal of Clinical Oncology. 37: TPS5091-TPS5091. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps5091  0.351
2018 Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, ... ... Chou J, et al. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 175: 889. PMID 30340047 DOI: 10.1016/J.Cell.2018.10.019  0.309
2018 Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, ... ... Chou J, et al. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. PMID 30033370 DOI: 10.1016/J.Cell.2018.06.039  0.354
2018 Kornberg Z, Chou J, Feng FY, Ryan CJ. Prostate cancer in the era of "Omic" medicine: recognizing the importance of DNA damage repair pathways. Annals of Translational Medicine. 6: 161. PMID 29911109 DOI: 10.21037/Atm.2018.05.06  0.339
2018 Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, et al. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. Cell. 173: 1770-1782.e14. PMID 29906450 DOI: 10.1016/J.Cell.2018.04.034  0.351
2018 Devignes CS, Aslan Y, Brenot A, Devillers A, Schepers K, Fabre S, Chou J, Casbon AJ, Werb Z, Provot S. HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 29339479 DOI: 10.1073/Pnas.1718009115  0.537
2017 Shahi P, Wang CY, Chou J, Hagerling C, Gonzalez Veloso H, Ruderisch A, Yu Y, Lai MD, Werb Z. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis. Oncogene. PMID 28581515 DOI: 10.1038/Onc.2017.165  0.602
2016 Chou J, Chan MF, Werb Z. Metalloproteinases: a Functional Pathway for Myeloid Cells. Microbiology Spectrum. 4. PMID 27227311 DOI: 10.1128/Microbiolspec.Mchd-0002-2015  0.49
2016 Devignes C, Brenot A, Devillers A, Fabre S, Aslan Y, Schepers K, Chou J, Casbon A, Werb Z, Provot S. La signalisation HIF dans les ostéoprogéniteurs stimule la croissance et la dissémination des tumeurs mammaires Revue Du Rhumatisme. 83: A103-A104. DOI: 10.1016/S1169-8330(16)30363-5  0.402
2015 Shahi P, Slorach EM, Wang CY, Chou J, Lu A, Ruderisch A, Werb Z. The Transcriptional Repressor ZNF503/Zeppo2 Promotes Mammary Epithelial Cell Proliferation and Enhances Cell Invasion. The Journal of Biological Chemistry. 290: 3803-13. PMID 25538248 DOI: 10.1074/Jbc.M114.611202  0.573
2015 Plaks V, Chou J, Maynard C, Nguyen NH, Kong N, Solomonov I, Talmi-Frank D, Bonnans C, Sagi I, Werb Z. Abstract 4724: Targeting matrix metalloproteinases (MMP) for anti-metastatic therapy: Blocking active MMP9 abrogates metastatic niche formation and prevents metastatic seeding in a breast cancer model Cancer Research. 75: 4724-4724. DOI: 10.1158/1538-7445.Am2015-4724  0.548
2014 Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nature Reviews. Molecular Cell Biology. 15: 786-801. PMID 25415508 DOI: 10.1038/Nrm3904  0.493
2014 Shahi P, Slorach EM, Chou J, Lawson D, Yu Y, Werb Z. Abstract 2475: Zpo2 promotes aggressive breast cancer development through downregulation of GATA3 Cancer Research. 74: 2475-2475. DOI: 10.1158/1538-7445.Am2014-2475  0.603
2013 Chou J, Shahi P, Werb Z. microRNA-mediated regulation of the tumor microenvironment. Cell Cycle (Georgetown, Tex.). 12: 3262-71. PMID 24036551 DOI: 10.4161/Cc.26087  0.497
2013 Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nature Cell Biology. 15: 201-13. PMID 23354167 DOI: 10.1038/Ncb2672  0.551
2012 Chou J, Werb Z. MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironment. Cancer Discovery. 2: 1078-80. PMID 23230184 DOI: 10.1158/2159-8290.Cd-12-0465  0.52
2012 Littlepage LE, Adler AS, Kouros-Mehr H, Huang G, Chou J, Krig SR, Griffith OL, Korkola JE, Qu K, Lawson DA, Xue Q, Sternlicht MD, Dijkgraaf GJ, Yaswen P, Rugo HS, et al. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression. Cancer Discovery. 2: 638-51. PMID 22728437 DOI: 10.1158/2159-8290.Cd-12-0093  0.694
2011 Slorach EM, Chou J, Werb Z. Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes & Development. 25: 471-84. PMID 21317240 DOI: 10.1101/Gad.1998111  0.571
2010 Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it! Journal of Cellular Physiology. 222: 42-9. PMID 19798694 DOI: 10.1002/Jcp.21943  0.588
Show low-probability matches.